All Stories

  1. Adverse reactions in mRCC patients documented in routine practice by German office-based oncologists and uro-oncologists

    Article • Journal of Oncology Pharmacy Practice, February 2016, SAGE Publications

    Dr Norbert W Marschner

  2. Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

    Article • Clinical Epidemiology, April 2015, Taylor & Francis

    Dr Norbert W Marschner

  3. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomi...

    Article • The Lancet Oncology, October 2014, Elsevier

    Dr Norbert W Marschner, Fabio Puglisi

  4. Routine treatment of patients with chronic lymphocytic leukaemia by office‐based haematologists in Germany—data from the Prospective Tumour Registry Lymphatic Neoplasms

    Article • Hematological Oncology, April 2014, Wiley

    Dr Norbert W Marschner

  5. Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective

    Article • Breast Care, January 2014, Karger Publishers

    Dr Norbert W Marschner

  6. Treatment Algorithm for Metastatic Renal Cell Carcinoma - Recommendations Based on Evidence and Clinical Practice

    Article • Oncology Research and Treatment, January 2014, Karger Publishers

    Dr Norbert W Marschner

  7. OR39 OVERALL SURVIVAL AND SEQUENTIAL TREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS – OUTCOME DATA FROM THE TMK REGISTRY GROUP

    Article • The Breast, November 2013, Elsevier

    Dr Norbert W Marschner

  8. BP41 EFFECTIVENESS OF TAXANE- OR ANTHRACYLINE-BASED COMPARED TO TAXANE- AND ANTHRACYLINE-FREE FIRST-LINE TREATMENTS OF PATIENTS WITH METASTATIC BREAST CANCER TREATED BY GERMAN OFFICE-BASED MEDICAL ONCOLOGISTS. DATA FROM THE TMK REGISTRY GROUP

    Article • The Breast, November 2013, Elsevier

    Dr Norbert W Marschner

  9. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

    Article • Breast Care, January 2013, Karger Publishers

    Dr Norbert W Marschner

  10. Akademische multizentrische Studien im Fokus: Auswirkungen der Arzneimittelgesetzgebung auf Therapieoptimierungsstudien in der Hämatologie/Onkologie

    Article • Onkologie, January 2013, Karger Publishers

    Dr Norbert W Marschner

  11. 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

    Article • Breast Care, January 2013, Karger Publishers

    Dr Norbert W Marschner

  12. Long-Term Disease Stabilization in a Patient with Castration-Resistant Metastatic Prostate Cancer by the Addition of Lenalidomide to Low-Dose Dexamethasone and Celecoxib

    Article • Onkologie, January 2012, Karger Publishers

    Dr Norbert W Marschner

  13. ABC1 Consensus Conference – a German Perspective

    Article • Breast Care, January 2012, Karger Publishers

    Dr Norbert W Marschner

  14. Networking Against Cancer

    Article • Breast Care, January 2011, Karger Publishers

    Dr Norbert W Marschner

  15. Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011)

    Article • Breast Care, January 2011, Karger Publishers

    Dr Norbert W Marschner

  16. Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies

    Article • Medical Oncology, October 2010, Springer Science + Business Media

    Dr Norbert W Marschner

  17. Sunitinib im klinischen Alltag: Das Expanded-Access-Programm beim metastasierten Nierenzellkarzinom

    Article • Onkologie, January 2010, Karger Publishers

    Dr Norbert W Marschner

  18. Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy

    Article • Urologia Internationalis, January 2010, Karger Publishers

    Dr Norbert W Marschner

  19. Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

    Article • New England Journal of Medicine, June 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Norbert W Marschner

  20. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment

    Article • Cancer Chemotherapy and Pharmacology, January 1992, Springer Science + Business Media

    Dr Norbert W Marschner

  21. Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

    Article • European Journal of Cancer and Clinical Oncology, September 1991, Elsevier

    Dr Norbert W Marschner

  22. Medikament�se Therapie des Erbrechens bei Tumorpatienten

    Article • Karger Publishers

    Dr Norbert W Marschner

  23. Determination of Alkylphosphocholines and of Alkyl-glycero-phosphocholines in Biological Fluids and Tissues

    Article • Karger Publishers

    Dr Norbert W Marschner